FDA Adverse Event Injury Summary report: N

VITALITY

MDR report key: 1852928 · Received October 5, 2010

Report

Report Number
2124215-2010-15521
Event Type
Injury
Date Received
October 5, 2010
Date of Event
May 17, 2010
Report Date
July 13, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE [DEFIBRILLATION], PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED. THE INITIAL ALLEGATION OF HIGH PACING IMPEDANCE VALUES WAS NOT CONFIRMED BY ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED AN INCREASE IN RIGHT VENTRICULAR (RV) PACING IMPEDANCE FROM 758 OHMS TO 1888 OHMS OVER THE PAST SEVERAL MONTHS. THE SHOCK IMPEDANCE VALUE WAS NOTED AS BEING 48 OHMS, THERE WAS ONE NON-SUSTAINED VENTRICULAR TACHYCARDIA (VT) EPISODE, AND THE THRESHOLD INCREASED FROM 1.6 V TO 2.0 V. THIS PATIENT IS GOING TO VISIT HIS/HER IMPLANT HOSPITAL IN THE NEAR FUTURE. SUBSEQUENTLY, ADDITIONAL INFORMATION WAS RECEIVED THAT THE RV PACING IMPEDANCE VALUE WAS MEASURED AS 2834 OHMS. THE PHYSICIAN ELECTED TO EXPLANT THIS ICD ALONG WITH THE REST OF THE IMPLANTED SYSTEM DUE TO THE POSSIBILITY OF INFECTION. THERE WERE NO OTHER ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND 1871

Patients

Seq Age Sex Outcome Treatment
1 4472| 1871| 0174